发明名称 |
Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis |
摘要 |
<p>A method of treating chronic hepatitis B is disclosed that comprises administering a T cell-stimulating amount of a vaccine to a patient. The vaccine comprises an immunogenic amount of chimeric, carboxy-terminal truncated hepatitis B virus nucleocapsid (core) protein (HBc) that is engineered for both enhanced stability of self-assembled particles and the substantial absence of nucleic acid binding by those particles. The chimeric protein molecule can include one or more immunogenic epitopes peptide-bonded to one or more of the N-terminus, the immunogenic loop or the C-terminus of HBc. The enhanced stability of self-assembled particles is obtained by the presence of at least one heterologous cysteine residue near one or both of the amino-terminus and carboxy-terminus of the chimer molecule.</p> |
申请公布号 |
AU2004216246(A1) |
申请公布日期 |
2004.09.10 |
申请号 |
AU20040216246 |
申请日期 |
2004.02.20 |
申请人 |
LORANTIS LIMITED |
发明人 |
MARK PAGE;MARTIN FRIEDE;ANNETTE ELISABETH SCHMIDT;DETLEF STOBER |
分类号 |
A61K39/00;A61K39/29;C07K14/02;C12N7/04;C12N15/36;(IPC1-7):C07K14/02 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|